This site is intended for healthcare professionals
  • Home
  • /
  • Guidelines
  • /
  • lung Cancer
  • /
  • Metastatic Non-Small-Cell Lung Cancer: ESMO Clinic...
Guideline

Metastatic Non-Small-Cell Lung Cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Read time: 1 mins
Last updated:14th Sep 2020
Status: Current
Metastatic Non-Small-Cell Lung Cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up


The ESMO Clinical Practice Guidelines on Metastatic non-small cell lung cancer (NSCLC) are based on results from recent studies and analyses. The guidelines focus on treatment recommendations for the management of advanced/metastatic NSCLC, with an update on the role of immunotherapy and the use of targeted therapies for patients with tumours with specific gene mutations. Also covered are personalised medicine recommendations and new treatment algorithms.


Read full Guideline